Synopsis
Synopsis
0
VMF
0
Australia
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol Hcl
2. Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, Hydrochloride
3. Dobupal
4. Efexor
5. Effexor
6. Hydrochloride, Venlafaxine
7. Sila Venlafaxine
8. Sila-venlafaxine
9. Trevilor
10. Vandral
11. Venlafaxine
12. Wy 45,030
13. Wy 45030
14. Wy-45,030
15. Wy-45030
16. Wy45,030
17. Wy45030
1. 99300-78-4
2. Venlafaxine Hcl
3. Effexor
4. Efexor
5. Effexor Xr
6. Dobupal
7. Vandral
8. Venlafaxinehydrochloride
9. Wy-45030
10. Venlafaxine (hydrochloride)
11. Wy 45030
12. Wy-45,030
13. Wy 45030 Hydrochloride
14. 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol Hydrochloride
15. 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol Hydrochloride
16. Nsc-745751
17. 7d7rx5a8mo
18. Venlafaxine (as Hydrochloride)
19. 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol Hydrochloride
20. Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, Hydrochloride
21. 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexan-1-ol Hydrochloride
22. 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol;hydrochloride
23. Chebi:9944
24. Venlafaxine Hydrochloride [usan]
25. Venlafaxine Hydorchloride
26. Unii-7d7rx5a8mo
27. C17h27no2.hcl
28. Venlift
29. Vexor
30. D,l-venlafaxine, Hydrochloride
31. Venlafaxine Ea
32. Venlafaxine Xr
33. Effexor Lp
34. Effexor Xl
35. Efexor Xl
36. Venlafaxine, Hcl
37. Effexor (tn)
38. Venlafaxine Hydrochloride [usan:usp]
39. Venlafaxine Hydro Chloride
40. Dsstox_cid_27397
41. Dsstox_rid_82318
42. Dsstox_gsid_47397
43. Schembl41936
44. Mls001401454
45. Chembl1201066
46. Dtxsid8047397
47. Hy-b0196a
48. Bvf-012
49. Amy32694
50. Bcp21401
51. Dl-venlafaxine Hydrochloride- Bio-x
52. Tox21_302508
53. Tox21_500449
54. Nsc745751
55. S1441
56. Venlafaxine Hydrochloride (jan/usp)
57. Venlafaxine Hydrochloride [mi]
58. Akos000280874
59. Akos016340594
60. Ac-1696
61. Ccg-100979
62. Ccg-213270
63. H13v695
64. Ks-5049
65. Lp00449
66. Nc00229
67. Nsc 745751
68. Pw-4112
69. Venlafaxine Hydrochloride [jan]
70. Venlafaxine Hydrochloride [hsdb]
71. Ncgc00256703-01
72. Ncgc00261134-01
73. Venlafaxine Hydrochloride [mart.]
74. Venlafaxine Hydrochloride [vandf]
75. Bv164514
76. Smr000469154
77. Venlafaxine Hydrochloride [usp-rs]
78. Venlafaxine Hydrochloride [who-dd]
79. Cas-99300-78-4
80. Ft-0642395
81. Sw197609-3
82. V0110
83. Pf-00345408
84. D00821
85. Venlafaxine Hydrochloride [ep Impurity]
86. Venlafaxine Hydrochloride [ep Monograph]
87. Venlafaxine Hydrochloride [orange Book]
88. Venlafaxine Hydrochloride [usp Monograph]
89. A845995
90. Venlafaxine Hydrochloride, >=98% (hplc), Powder
91. Venlafaxine Hydrochloride 100 Microg/ml In Methanol
92. Q27108525
93. Venlafaxine Hydrochloride 100 Microg/ml In Acetonitrile
94. 1-[2-dimethylamino-1-(4-methoxyphenyl)ethyl]cyclohexanol -hcl
95. Venlafaxine Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
96. 1-[2-(dimethylamino)-1-(4-methoxyph Enyl)ethyl]cyclohexanol Hydrochloride
97. 1-[2-dimethylamino-1-(4-methoxy-phenyl)-ethyl]-cyclohexanol Hydrochloride
98. Venlafaxine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
99. (+/-)-1-(.alpha.-((dimethylamino)methyl)-p-methoxybenzyl)cyclohexanol Hydrochloride
100. (rs)-1-(2-dimethylamino-1-(4-methoxyphenyl)ethyl)cyclohexanol Hydrochloride
101. 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-1-cyclohexanol Hydrochloride
102. Cyclohexanol, 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-, Hydrochloride (1:1
103. Venlafaxine For System Suitability, European Pharmacopoeia (ep) Reference Standard
104. Venlafaxine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
105. Venlafaxine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
106. Venlafaxine Hydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
Molecular Weight | 313.9 g/mol |
---|---|
Molecular Formula | C17H28ClNO2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 5 |
Exact Mass | 313.1808568 g/mol |
Monoisotopic Mass | 313.1808568 g/mol |
Topological Polar Surface Area | 32.7 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 279 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Effexor xr |
Drug Label | Effexor XR is an extended-release capsule for oral administration that contains venlafaxine hydrochloride, a structurally novel antidepressant. It is designated (R/S)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride or ()-1... |
Active Ingredient | Venlafaxine hydrochloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | eq 150mg base; eq 37.5mg base; eq 75mg base |
Market Status | Prescription |
Company | Wyeth Pharms |
2 of 4 | |
---|---|
Drug Name | Venlafaxine hydrochloride |
PubMed Health | Venlafaxine (By mouth) |
Drug Classes | Antidepressant |
Drug Label | Venlafaxine hydrochloride extended-release capsules for oral administration contain venlafaxine hydrochloride, a structurally novel antidepressant. It is designated (R/S)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride or (c... |
Active Ingredient | Venlafaxine hydrochloride |
Dosage Form | Tablet, extended release; Tablet; Capsule, extended release |
Route | oral; Oral |
Strength | 37.5mg; eq 100mg base; eq 225mg base; eq 50mg base; 150mg; eq 150mg base; eq 75mg base; 75mg; eq 25mg base; eq 37.5mg base |
Market Status | Tentative Approval; Prescription |
Company | Amneal Pharms; Wockhardt; Anchen Pharms; Teva; Alembic Pharms; Aurobindo Pharma; Sun Pharm Inds; Torrent Pharms; Osmotica Pharm; Sun Pharma Global; Vintage; Valeant Bermuda; Zydus Pharms Usa; Dr Reddys Labs; Orchid Hlthcare; Mylan; Impax Labs; Heritage Ph |
3 of 4 | |
---|---|
Drug Name | Effexor xr |
Drug Label | Effexor XR is an extended-release capsule for oral administration that contains venlafaxine hydrochloride, a structurally novel antidepressant. It is designated (R/S)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride or ()-1... |
Active Ingredient | Venlafaxine hydrochloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | eq 150mg base; eq 37.5mg base; eq 75mg base |
Market Status | Prescription |
Company | Wyeth Pharms |
4 of 4 | |
---|---|
Drug Name | Venlafaxine hydrochloride |
PubMed Health | Venlafaxine (By mouth) |
Drug Classes | Antidepressant |
Drug Label | Venlafaxine hydrochloride extended-release capsules for oral administration contain venlafaxine hydrochloride, a structurally novel antidepressant. It is designated (R/S)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride or (c... |
Active Ingredient | Venlafaxine hydrochloride |
Dosage Form | Tablet, extended release; Tablet; Capsule, extended release |
Route | oral; Oral |
Strength | 37.5mg; eq 100mg base; eq 225mg base; eq 50mg base; 150mg; eq 150mg base; eq 75mg base; 75mg; eq 25mg base; eq 37.5mg base |
Market Status | Tentative Approval; Prescription |
Company | Amneal Pharms; Wockhardt; Anchen Pharms; Teva; Alembic Pharms; Aurobindo Pharma; Sun Pharm Inds; Torrent Pharms; Osmotica Pharm; Sun Pharma Global; Vintage; Valeant Bermuda; Zydus Pharms Usa; Dr Reddys Labs; Orchid Hlthcare; Mylan; Impax Labs; Heritage Ph |
Antidepressive Agents, Second-Generation
A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)
Serotonin and Noradrenaline Reuptake Inhibitors
Drugs that selectively block or suppress the plasma membrane transport of SEROTONIN and NORADRENALINE into axon terminals and are used as ANTIDEPRESSIVE AGENTS. (See all compounds classified as Serotonin and Noradrenaline Reuptake Inhibitors.)
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2022-11-03
Pay. Date : 2022-10-12
DMF Number : 34507
Submission : 2020-01-11
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-04-10
Pay. Date : 2013-04-02
DMF Number : 17258
Submission : 2004-03-01
Status : Active
Type : II
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
GDUFA
DMF Review : Complete
Rev. Date : 2016-02-12
Pay. Date : 2016-01-28
DMF Number : 19879
Submission : 2006-10-11
Status : Active
Type : II
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
GDUFA
DMF Review : Complete
Rev. Date : 2017-05-26
Pay. Date : 2015-07-13
DMF Number : 28433
Submission : 2014-07-28
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2012-12-24
Pay. Date : 2012-11-13
DMF Number : 16281
Submission : 2002-12-02
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18983
Submission : 2005-11-28
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8971
Submission : 1991-02-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8967
Submission : 1991-02-15
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10005
Submission : 1992-12-15
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Application : Coating Systems & Additives
Excipient Details : ACTILLETS™ are microcrystalline cellulose spheres used in advanced drug formulations as starter cores for drug layering and coating.
Pharmacopoeia Ref : NA
Technical Specs : Bulk density: 0.80
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Orodispersible Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : CM90 is a directly compressible, granulated calcium carbonate with maltodextrin used for swallow tablets due to its high density and compressibility.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 490- 500, Tapped Density: 1.50
Ingredient(s) : Calcium Carbonate Excipient
Dosage Form : Orodispersible Tablet
Grade : Oral
Dosage Form : Orodispersible Tablet
Grade : Oral
Application : Chewable & Orodispersible Aids
Excipient Details : CS90 is a directly compressible calcium carbonate with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-175, Tapped Density: 0.85
Ingredient(s) : Calcium Carbonate Excipient
Dosage Form : Tablet
Grade : Oral
Dosage Form : Orodispersible Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Excipients by Applications
Global Sales Information
Market Place
Reply
03 Jan 2025
Reply
05 Dec 2024
Reply
16 Jul 2024
Reply
13 Jun 2024
Reply
14 Jan 2023
Reply
28 Feb 2022
Reply
23 Nov 2021
Reply
01 Feb 2021
Reply
25 Jan 2020
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
Analyte : Venlafaxine
Method : HPLC/MS/MS
LLOQ : 0.5
Units : ng/ml
Details :
ABOUT THIS PAGE
A Venlafaxine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Venlafaxine Hydrochloride, including repackagers and relabelers. The FDA regulates Venlafaxine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Venlafaxine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Venlafaxine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Venlafaxine Hydrochloride supplier is an individual or a company that provides Venlafaxine Hydrochloride active pharmaceutical ingredient (API) or Venlafaxine Hydrochloride finished formulations upon request. The Venlafaxine Hydrochloride suppliers may include Venlafaxine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Venlafaxine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Venlafaxine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Venlafaxine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Venlafaxine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Venlafaxine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Venlafaxine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Venlafaxine Hydrochloride USDMF includes data on Venlafaxine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Venlafaxine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Venlafaxine Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Venlafaxine Hydrochloride Drug Master File in Japan (Venlafaxine Hydrochloride JDMF) empowers Venlafaxine Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Venlafaxine Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Venlafaxine Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Venlafaxine Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Venlafaxine Hydrochloride Drug Master File in Korea (Venlafaxine Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Venlafaxine Hydrochloride. The MFDS reviews the Venlafaxine Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Venlafaxine Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Venlafaxine Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Venlafaxine Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Venlafaxine Hydrochloride suppliers with KDMF on PharmaCompass.
A Venlafaxine Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Venlafaxine Hydrochloride Certificate of Suitability (COS). The purpose of a Venlafaxine Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Venlafaxine Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Venlafaxine Hydrochloride to their clients by showing that a Venlafaxine Hydrochloride CEP has been issued for it. The manufacturer submits a Venlafaxine Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Venlafaxine Hydrochloride CEP holder for the record. Additionally, the data presented in the Venlafaxine Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Venlafaxine Hydrochloride DMF.
A Venlafaxine Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Venlafaxine Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Venlafaxine Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Venlafaxine Hydrochloride written confirmation (Venlafaxine Hydrochloride WC) is an official document issued by a regulatory agency to a Venlafaxine Hydrochloride manufacturer, verifying that the manufacturing facility of a Venlafaxine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Venlafaxine Hydrochloride APIs or Venlafaxine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Venlafaxine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Venlafaxine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Venlafaxine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Venlafaxine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Venlafaxine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Venlafaxine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Venlafaxine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Venlafaxine Hydrochloride suppliers with NDC on PharmaCompass.
Venlafaxine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Venlafaxine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Venlafaxine Hydrochloride GMP manufacturer or Venlafaxine Hydrochloride GMP API supplier for your needs.
A Venlafaxine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Venlafaxine Hydrochloride's compliance with Venlafaxine Hydrochloride specifications and serves as a tool for batch-level quality control.
Venlafaxine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Venlafaxine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Venlafaxine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Venlafaxine Hydrochloride EP), Venlafaxine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Venlafaxine Hydrochloride USP).
LOOKING FOR A SUPPLIER?